<!doctype html public "-//IETF//DTD HTML//EN">
<html>

<head>
<meta NAME="GENERATOR" CONTENT="Microsoft FrontPage 6.0">
<meta NAME="BUILD" CONTENT="Feb 16 1998">
<title>PHARMACY PRACTICE AND SCIENCE (PHPR)</title>
<meta NAME="AUTHOR" CONTENT="OCIAI">
<meta NAME="OPERATOR" CONTENT="OCIAI">
<meta NAME="CREATIM" CONTENT="1998:2:16:10:50:">
<meta NAME="VERSION" CONTENT="2">

<meta content="b" name="Microsoft Border">
</head>

<body BACKGROUND="../../../images/images1998/biga.gif"><!--msnavigation--><table border="0" cellpadding="0" cellspacing="0" dir="ltr" width="100%"><tr><!--msnavigation--><td valign="top"><!--msnavigation--><msnavigation border="0" cellpadding="0" cellspacing="0" dir="ltr" width="100%"><tr><!--msnavigation--><msnavigation valign="top"><!--msnavigation--><msnavigation dir="ltr" border="0" cellpadding="0" cellspacing="0" width="100%"><tr><!--msnavigation--><msnavigation valign="top">

<dl>
  <dd align="center"><img src="../../../images/images1998/courses.jpg" alt WIDTH="400" HEIGHT="50"> </dd>
  <p><a href="crsdesc.htm"><strong>How to read course descriptions</strong></a></p>
  <b><p>PHARMACY PRACTICE AND SCIENCE (PHPR)</b></p>
  <p><b><a name="PHPR195" >195.</a> Colloquium </b></p>
  <p>a. Perspectives on Health Care: Current Issues and Trends (1) I </p>
  <p>c . Medication Misadventures (1) I </p>
  <p><b><a name="PHPR299" >299.</a> Independent Study </b>(1-3)
  [Rpt./] </p>
  <p><b><a name="PHPR394" >394.</a> Practicum </b>(1-4) [Rpt./] </p>
  <p><b><a name="PHPR399" >399.</a> Independent Study </b>(1-4)
  [Rpt./] </p>
  <p><b><a name="PHPR399H" >399H.</a> Honors Independent Study </b>(1-3)
  [Rpt./] </p>
  <p><b><a name="PHPR400" >400.</a> Pharmaceutical Calculations </b>(1)
  I Pharmaceutical calculations pertinent to the selection, formulation, preparation, dosage
  and administration of drugs and their dosage forms. </p>
  <p><b><a name="PHPR401" >401.</a> Dosage Form Design </b>(2)
  II Application of physical-chemical principles to pharmaceutical dosage forms, including a
  discussion of the biopharmaceutical considerations which influence the efficacy of
  pharmaceutical formulations. P, PHPR 402, PHPR 406. </p>
  <p><b><a name="PHPR402" >402.</a> Pharmaceutics </b>(3) I
  Discussion of the physical and chemical factors that relate to the development of
  pharmaceutical products and drug delivery systems. Emphasis is placed on newly emerging
  technologies and an industrial perspective. P, PHYS 102, PHYS 182, CHEM 103B, CHEM 104B. </p>
  <p><b><a name="PHPR403A" >403A.</a> Beginning Pharmacy Practice
  </b>(1) I Orientation to career opportunities for pharmacists; medical terminology and
  abbreviations. </p>
  <p><b><a name="PHPR403B" >403B.</a> Beginning Pharmacy Practice
  </b>(1) II Orientation to career opportunities for pharmacists; medical terminology and
  abbreviations. </p>
  <p><b><a name="PHPR404" >404.</a> Interviewing and Counseling
  Skills </b>(1-2) I Basic communication skills and thinking strategies needed for effective
  medication history interviewing and patient counseling. </p>
  <p><b><a name="PHPR406A" >406A.</a> Pharmaceutics Lab </b>(1) I
  P or CR, PHPR 402. </p>
  <p><b><a name="PHPR406B" >406B.</a> Pharmaceutics Lab </b>(1)
  II P, PHPR 406A. </p>
  <p><b><a name="PHPR407" >407.</a> Pharmacokinetics </b>(4) I
  Quantitative description of the processes of drug absorption, distribution and elimination
  and factors affecting those processes. Application of kinetic principles to chronic drug
  administration. P, PHPR 307. </p>
  <p><b><a name="PHPR408A" >408A.</a> Pharmacokinetics Discussion
  </b>(1) I II Discussion related to the application of pharmacokinetic principles with
  case-study examples. CR, PHPR 407. </p>
  <p><b><a name="PHPR408B" >408B.</a> Pharmacokinetics Discussion
  </b>(1) I II Discussion related to the application of pharmacokinetic principles with
  case-study examples. CR, PHPR 485. </p>
  <p><b><a name="PHPR410" >410.</a> Research Options in Pharmacy
  </b>(1) I Introduction to research in the pharmacy disciplines, career opportunities in
  pharmacy research; grants, contracts, and patents; confidentiality and ethics. </p>
  <p><b><a name="PHPR411" >411.</a> Perspectives in Professional
  Practice </b>(2) II Orientation to professional practice issues; pharmacy practice site
  visitations. Involves weekly discussions, site visits to various pharmacy practices, and a
  written paper. Field trip. P, open to majors only. </p>
  <p><b><a name="PHPR413" >413.</a> Pharmacy Practice </b>(2) II
  Application of pharmaceutical care principles, pharmacy problem-solving skills, role
  playing and documentation of pharmaceutical care. P, PHPR 407, PCOL 471B. </p>
  <p><b><a name="PHPR414" >414.</a> Pharmacy Practice Lab </b>(1)
  II Laboratory for 413. </p>
  <p><b><a name="PHPR415" >415.</a> Toxicokinetics </b>(3) II
  Introduction to the principles of pharmacokinetics as they are applied to the biological
  and chemical sciences for the quantitative study of drugs and toxic agents. Toxicokinetics
  involves the development of quantitative models to describe the time course of absorption
  toxicity, especially as it relates to the drug or toxin disposition. Issues in
  experimental design, extrapolation of data from animals to humans, and aspects of risk
  assessment. May be convened with PHSC 515. </p>
  <p><b><a name="PHPR416" >416.</a> Patient Assessment </b>(1-2)
  II The use of medical history taking, physical assessment, laboratory test interpretation,
  and physical diagnosis skills to monitor response to drug treatment and evaluate patient
  complaints/problems.</p>
  <p><b><a name="PHPR417" >417.</a> The Internet: Application
  and Use </b>(2) II Internet terms, concepts, tools, utilities, and resources. Application
  of Internet technologies for the delivery of pharmaceutical care and accessing health care
  information is emphasized. </p>
  <p><b><a name="PHPR422" >422.</a> Case Discussions in
  Medicinal Chemistry and Pharmacology </b>(1) I Student centered problem oriented
  discussions that stress application and integration of medicinal chemistry and
  pharmacology using simulated patient scenarios and cases. P, open to College of Pharmacy
  students only. </p>
  <p><b><a name="PHPR424" >424.</a> Antibiotics </b>(2) I
  Principles of antibiotic chemotherapy and the properties of the antibiotics employed in
  therapeutics. P, MIC 205, PCOL 471B. </p>
  <p><b><a name="PHPR425" >425.</a> Preparation for Pharmacy
  Clerkships</b> (1) I Weekly discussion to prepare students for pharmacy clerkships.
  Includes presentations by clerkship preceptors, curriculum vitae preparation, and
  professional portfolio development. P, open only to majors in 3rd year. </p>
  <p><b><a name="PHPR427" >427.</a> Anti-neoplastic Drugs </b>(2)
  II Discovery and development of natural and synthetic anti-neoplastic drugs; pre-clinical
  screening and toxicity evaluation; phase I, II, and III clinical studies in humans. P or
  CR, PHPR 437B. </p>
  <p><b><a name="PHPR432" >432.</a> Managed Health Care </b>(2)
  II An introduction to the concepts and various aspects of managed health care systems
  within the United States and roles for pharmacists. P, PHPR 445. </p>
  <p><b><a name="PHPR442" >442.</a> Professional Practice
  Management </b>(3) I Management of professional situations and the interaction among
  patients, colleagues, and other health-care providers, with application to institutional,
  community, and clinical pharmacy practice. P, PHPR 445. </p>
  <p><b><a name="PHPR443" >443.</a> Pharmacy Laws </b>(2) I
  Legal concepts covering professionalism, negligence, liability, legal processes and
  semantics; pertinent federal, state and local statutes and regulations. </p>
  <p><b><a name="PHPR445" >445.</a> Medication Use and the U.S.
  Health Care System </b>(3) I An overview of the U. S. health care system and the
  consumers, providers, payers, and regulators that comprise it. The role of pharmacy and
  pharmacists within the health care system will be explored, including an examination of
  social, behavioral, and economic factors associated with the prescribing, dispensing, and
  use of medications. </p>
  <p><b><a name="PHPR447" >447.</a> Perspectives in Geriatrics
  Laboratory </b>(1) II P, PHPR 448. (Identical with GERO 447, N SC 447). </p>
  <p><b><a name="PHPR448" >448.</a> Perspectives in Geriatrics </b>(2)
  II Multidisciplinary approach to the health-care needs of the elderly, including
  medication use, nutrition, health care agencies and roles of individual health care
  professionals. P, PHPR 447. Open to non-majors only. (Identical with GERO 448, N SC 448). </p>
  <p><b><a name="PHPR454" >454.</a> Drug Information and Drug
  Literature Evaluation </b>(3) I II Skills and principles of drug information,
  biostatistics, and literature evaluation needed to evaluate biomedical literature. P, PHPR
  403. </p>
  <p><b><a name="PHPR461" >461.</a> Methodology in Pharmacy
  Research and Drug Literature Evaluation </b>(3) I II Application of research design,
  statistical methods, evaluation techniques, and ethical dimensions to critically evaluate
  published literature, research reports and proposals. P, MATH 263. </p>
  <p><b><a name="PHPR473" >473.</a> </b><strong>Integrating
  Alternative Therapies into Pharmacy Practice</strong> (3) II This course will emphasize
  western botanicals, homeopathy, Chinese medicine and Ayurvedic medicine by comparing and
  contrasting their philosophic and therapeutic approach to Western medicine. P, PCOL 471B
  and PCOL 472.</p>
  <p><b><a name="PHPR475A" >475A.</a> Pharmacotherapeutics </b>(6)
  II Common diseases that afflict humans. Their management based on pharmacotherapeutic
  considerations of epidemiology, etiology, diagnosis, pathophysiology, and prognosis. P,
  BIOC 460, PSIO 480. </p>
  <p><b><a name="PHPR475B" >475B.</a> Pharmacotherapeutics </b>(6)
  I Common diseases that afflict humans. Their management based on pharmacotherapeutic
  considerations of epidemiology, etiology, diagnosis, pathophysiology, and prognosis. P,
  BIOC 460, PSIO 480. </p>
  <p><b><a name="PHPR475C" >475C.</a> Pharmacotherapeutics </b>(6)
  II Common diseases that afflict humans. Their management based on pharmacotherapeutic
  considerations of epidemiology, etiology, diagnosis, pathophysiology, and prognosis. P,
  BIOC 460, PSIO 480. </p>
  <p><b><a name="PHPR484" >484.</a> International Health Care
  and Pharmaceutical Systems </b>(1-3) [Rpt./] II III Comparative analysis of health care
  and pharmaceutical systems between US and selected countries in the world. May be convened
  with PHSC 584. </p>
  <p><b><a name="PHPR485" >485.</a> Advanced Clinical
  Pharmacokinetics </b>(3) II Advanced pharmacokinetic principles emphasizing the
  application of mathematical relationships to therapeutic drug monitoring in patient care
  situations. </p>
  <p><b><a name="PHPR487" >487.</a> Public Speaking and Teaching
  Techniques for Health Care Professionals </b>(2) I Public speaking and analysis of
  teaching techniques for health care professionals. Students develop speeches aimed at
  different target groups, participate in formal debate and prepare learning objectives and
  assessment questions. P, upper division standing in the College of Pharmacy, Medicine, or
  Nursing. (Identical with MED 487). <font color="#FF0000">Delete crosslist with MED
  (Identical with MED 487). Spring 99</font></p>
  <p><b><a name="PHPR489" >489.</a> Clinical Pharmacotherapy of
  Mental Disorders </b>(2) I A multidisciplinary approach to clinical psychopharmacology,
  therapeutics, and diagnosis of mental disorders for health professionals. </p>
  <p><b><a name="PHPR495" >495.</a> Colloquium</b></p>
  <p>a. Issues in Pharmacy (2) II </p>
  <p><b><a name="PHPR498" >498.</a> Senior Capstone </b>(1-3) I
  II </p>
  <p><b><a name="PHPR498H" >498H.</a> Honors Thesis </b>(3)
  [Rpt./ 2] I II </p>
  <p><b><a name="PHPR499" >499.</a> Independent Study </b>(1-4)
  [Rpt./] </p>
  <p><b><a name="PHPR499H" >499H.</a> Honors Independent Study </b>(3)
  [Rpt./] I II </p>
  <p><b><a name="PHPR579" >579.</a> Issues in Rural Health </b>(3)
  II (Identical with NURS 579, which is home). </p>
  <p><b><a name="PHPR599" >599.</a> Independent Study </b>(1-4)
  [Rpt./] </p>
  <p><b><a name="PHPR694" >694.</a> Practicum </b>(1-6) [Rpt./] </p>
  <p><b><a name="PHPR699" >699.</a> Independent Study </b>(1-4)
  [Rpt./] </p>
  <p><b><a name="PHPR803A" >803B.</a>Community Pharmacy Practice </b>(5-5)
  S P, available only after completion of all required and elective didactic coursework in
  the second professional year. 803A-803B are six week courses. </p>
  <p><b><a name="PHPR803C" >803C.</a> Ambulatory Pharmacy
  Practice </b>(5) P, available only after completion of all required and didactic
  coursework in the first three professional years. </p>
  <p><b><a name="PHPR803D" >803D.</a> Drug Information Practice </b>(5)
  [Rpt./] P, available only after completion of all required and didactic coursework in the
  first three professional years. </p>
  <p><b><a name="PHPR803E" >803E.</a> Adult Acute Care Pharmacy
  Practice </b>(5) [Rpt./] P, available only after completion of all required and didactic
  coursework in the first three professional years. </p>
  <p><b><a name="PHPR810A" >810A.</a> Internal Medicine </b>(5)
  [Rpt./] P, available only after completion of all required and didactic coursework in the
  first three professional years. </p>
  <p><b><a name="PHPR810B" >810B.</a> Surgery </b>(5) [Rpt./] P,
  available only after completion of all required and didactic coursework in the first three
  professional years. </p>
  <p><b><a name="PHPR810C" >810C.</a> Pediatrics </b>(5) [Rpt./]
  P, available only after completion of all required and didactic coursework in the first
  three professional years. </p>
  <p><b><a name="PHPR810D" >810D.</a> Geriatrics/Gerontology </b>(5)
  [Rpt./] P, available only after completion of all required and didactic coursework in the
  first three professional years. </p>
  <p><b><a name="PHPR810E" >810E.</a> Outpatient Practice </b>(5)
  [Rpt./] P, available only after completion of all required and didactic coursework in the
  first three professional years. </p>
  <p><b><a name="PHPR810F" >810F.</a> Emergency Services </b>(5)
  [Rpt./ 1] P, available only after completion of all required and didactic coursework in
  the first three professional years. </p>
  <p><b><a name="PHPR810G" >810G.</a> Acute Care </b>(5) [Rpt./]
  P, available only after completion of all required and didactic coursework in the first
  three professional years. </p>
  <p><b><a name="PHPR810H" >810H.</a> Clinical Pharmacokinetics </b>(5)
  [Rpt./] I II P, available only after completion of all required and didactic coursework in
  the first three professional years. </p>
  <p><b><a name="PHPR810I" >810I.</a> Psychopharmacy/Neurology </b>(5)
  [Rpt./ 1] P, available only after completion of all required and didactic coursework in
  the first three professional years. </p>
  <p><b><a name="PHPR810J" >810J.</a> Nutrition Support </b>(5)
  [Rpt./ 1] P, available only after completion of all required and didactic coursework in
  the first three professional years. </p>
  <p><b><a name="PHPR810K" >810K.</a> Specialty Institution </b>(5)
  [Rpt./ 1] P, available only after completion of all required and didactic coursework in
  the first three professional years. </p>
  <p><b><a name="PHPR815A" >815A.</a> Hematology/Oncology </b>(5)
  [Rpt./ 1] P, available only after completion of all required and didactic coursework in
  the first three professional years. </p>
  <p><b><a name="PHPR815B" >815B.</a> Cardiology </b>(5) [Rpt./
  1] P, available only after completion of all required and didactic coursework in the first
  three professional years. </p>
  <p><b><a name="PHPR815C" >815C.</a> Pulmonary </b>(5) [Rpt./ 1]
  P, available only after completion of all required and didactic coursework in the first
  three professional years. </p>
  <p><b><a name="PHPR815D" >815D.</a> Endocrine </b>(5) [Rpt./ 1]
  P, available only after completion of all required and didactic coursework in the first
  three professional years. </p>
  <p><b><a name="PHPR815E" >815E.</a> GI/Renal </b>(5) [Rpt./ 1]
  P, available only after completion of all required and didactic coursework in the first
  three professional years. </p>
  <p><b><a name="PHPR815F" >815F.</a> Ob/Gyn/Neonatal </b>(5)
  [Rpt./ 1] P, available only after completion of all required and didactic coursework in
  the first three professional years. </p>
  <p><b><a name="PHPR815G" >815G.</a> Infectious Disease </b>(5)
  [Rpt./ 1] P, available only after completion of all required and didactic coursework in
  the first three professional years. </p>
  <p><b><a name="PHPR815H" >815H.</a> Rheumatology/Immunology </b>(5)
  [Rpt./ 1] P, available only after completion of all required and didactic coursework in
  the first three professional years. </p>
  <p><b><a name="PHPR815I" >815I.</a> Dermatology </b>(5) [Rpt./
  1] P, available only after completion of all required and didactic coursework in the first
  three professional years. </p>
  <p><b><a name="PHPR815J" >815J.</a> Poison
  Information/Toxicology </b>(5) [Rpt./ 1] P, available only after completion of all
  required and didactic coursework in the first three professional years. </p>
  <p><b><a name="PHPR815K" >815K.</a> Administrative </b>(5)
  [Rpt./ 1] P, available only after completion of all required and didactic coursework in
  the first three professional years. </p>
  <p><b><a name="PHPR815L" >815L.</a> Research </b>(5) [Rpt./ 1]
  P, available only after completion of all required and didactic coursework in the first
  three professional years. (Identical with PCOL 815L, PHSC 815L). </p>
  <p><b><a name="PHPR896" >896.</a> Seminar</b></p>
  <p>a. Pharmacy Practice Project (2) II </p>
  <p><b><a name="PHPR900" >900.</a> Research </b>(1-6) [Rpt./] </p>
  <p><b><a name="PHPR910" >910.</a> Thesis </b>(1-6) [Rpt./] </p>
  <p><b><a name="PHPR920" >920.</a> Dissertation </b>(1-9)
  [Rpt./] </p>
  <p><b><a name="PHPR930" >930.</a> Supplementary Registration </b>(1-9)
  [Rpt./] </p>
  <hr>
  <h5 align="left"><a href="../../../policies/984/policies.html">Academic Policies</a>|<a href="../../../geninfo/college/984/college.html">College Information</a>|<a href="../../../geninfo/dept/984/dept.html">Department Information</a>|<a href="courses.html">List of Courses</a>|<a href="../../../catalog1998/majors.html">Undergraduate
  Majors</a>|<a href="../../../catalog1998/minors.html">Undergraduate Minors</a>|<a href="http://www.arizona.edu/topics/academics">Academic Program
  Requirements Reports</a>|<a href="http://www.arizona.edu/topics/academics">Minor Requirement
  Reports</a>|<a href="../../../catalog1998/9899cal.html">Academic Calendar</a>|<a href="https://uaccess.schedule.arizona.edu/psp/uazsaprd2/UA_SCHEDULE/HRMS/h/?tab=DEFAULT"><em>Schedule of Classes</em></a>|<a href="http://www.registrar.arizona.edu">Important Deadlines</a>|<a href="../../984/alpha/alpha.html">List of Faculty</a>|<a href="../../../policies/984/accred.htm">Accreditations and Affiliations</a>|<a href="http://grad.arizona.edu/Catalog/"><em>Graduate Catalog</em></a>|<a href="../../../allcats.html">Previous Catalogs</a>|<a href="../../../catreq.htm">Order a Catalog</a>|<a href="../../../policies/984/respons.htm">Student Responsibility</a>|<a href="../../../catalog1998/index.html">Home</a></h5>
</dl>

<!--msnavigation--></td></tr><!--msnavigation--></table><!--msnavigation--><msnavigation border="0" cellpadding="0" cellspacing="0" width="100%"><tr><td>

<hr noshade size="1" width="90%">
<p align="center">Page last updated:&nbsp; May 20, 2013</p>
<p align="center">
<!-- Page last updated:&nbsp;
<!--webbot bot="Timestamp" s-type="EDITED" s-format="%B %d, %Y" --><br>
<font size="2">Arizona Board of Regents � All rights reserved.<br>General 
Catalog&nbsp; <a href="../../../index.html">http://catalog.arizona.edu/</a><br>
The University of Arizona</font></p>

</td></tr><!--msnavigation--></table><!--msnavigation--></td></tr><!--msnavigation--></table><!--msnavigation--><msnavigation border="0" cellpadding="0" cellspacing="0" width="100%"><tr><td background="../../../images/images1998/biga.gif">

<hr noshade size="1" width="90%">
<p align="center">Page last updated:&nbsp; May 20, 2013</p>
<p align="center">
<!-- Page last updated:&nbsp;
<!--webbot bot="Timestamp" s-type="EDITED" s-format="%B %d, %Y" --><br>
<font size="2">Arizona Board of Regents © All rights reserved.<br>General 
Catalog&nbsp; <a href="../../../index.html">http://catalog.arizona.edu/</a><br>
The University of Arizona</font></p>

</td></tr><!--msnavigation--></table><!--msnavigation--></td></tr><!--msnavigation--></table><!--msnavigation--><table border="0" cellpadding="0" cellspacing="0" width="100%"><tr><td background="../../../images/images1998/biga.gif">

<hr noshade size="1" width="90%">
<p align="center">Page last updated:&nbsp; May 20, 2013</p>
<p align="center">
<!-- Page last updated:&nbsp;
<!--webbot bot="Timestamp" s-type="EDITED" s-format="%B %d, %Y" --><br>
<font size="2">Arizona Board of Regents © All rights reserved.<br>General 
Catalog&nbsp; <a href="../../../index.html">http://catalog.arizona.edu/</a><br>
The University of Arizona</font></p>

</td></tr><!--msnavigation--></table></body>
</html>
